National database for cerebrovascular disease

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to identify prognostic predictors for cerebrovascular diseases by systematically collecting data from various stages of patient care, including hospitalization, neurorehabilitation, outpatient visits, and day hospital admissions. By gathering extensive data across multiple facilities, the study seeks to establish causal links and identify factors influencing patient outcomes. The initiative is part of a broader effort by the Ministry of Health to create a network for neuroscience and neurorehabilitation, enhancing the understanding and management of cerebrovascular conditions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of cerebrovascular pathology defined according to the 1990 NINDS special report2 as "all disorders in which an area of the brain is transiently or permanently affected by ischemia or bleeding and/or in which one or more of the blood vessels of the brain are primarily altered by a pathological process," falling under the following International Classification of Diseases, 9th revision (ICD-9) codes: ICD-9 430-438;
* Informed consent provided by the patient or the patient's legal representative in the case of incapacitation, or by the parents/guardians in the case of minor subjects.

Exclusion Criteria:

* The patient, his or her legal representative in the case of incapacitation, or his or her parents/guardians in the case of minor subjects irrefutably express the will to leave the study;
* Onset of cerebrovascular disease before January 1, 2016.

Where it's running

• IRCCS Don Gnocchi
  Florence, Fi, Italy Recruiting

Study contacts

• Study coordinator: Francesca Cecchi
• Email: fcecchi@dongnocchi.it
• Phone: 3388627184

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Brain recovery after MCA reopening is studied with PET/MR

  This study tests how brain blood flow, metabolism, and networks change after reopening a non-acute atherosclerotic middle cerebral artery occlusion in adults receiving recanalization treatment.

  Recruiting Qianfoshan Hospital · Jinan, Shandong · NCT07927569

• NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa

  This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.

  Recruiting University of Eastern Finland · Savonlinna · NCT07820800

• Tegoprazan to prevent GI complications in ischemic stroke patients on antiplatelet therapy

  This trial tests whether tegoprazan can lower gastrointestinal complications in adults with ischemic stroke or TIA who are starting antiplatelet therapy.

  Recruiting at 24 sites Phase 3 Hanyang University · Busan, Busan and 23 other locations · NCT07687706

• Scalp nerve block with liposomal versus standard bupivacaine for post-craniotomy pain relief

  This trial will test whether adding liposomal bupivacaine to scalp nerve blocks gives longer, better pain relief than standard bupivacaine for adults after elective craniotomy.

  Recruiting Phase 4 Zhejiang University · Hangzhou, Zhejiang · NCT07049094

• Cohort study on imaging methods for cerebrovascular disease

  This study is testing different imaging methods to see how they can help understand and improve outcomes for people who have had a stroke.

  Recruiting Beijing Tiantan Hospital · Beijing, Beijing Municipality · NCT06925178

• Using QDSA technology to assess cerebrovascular diseases

  This study is trying to see if a new imaging technology can help doctors better understand and treat patients with cerebrovascular diseases by tracking their health over time.

  Recruiting Beijing Tiantan Hospital · Beijing, Beijing Municipality · NCT06902415

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.